A prospective, randomized trial comparing BioGlue and Vivostat for the control of alveolar air leak
E. Belcher, M. Dusmet, S. Jordan, G. Ladas, E. Lim, P. Goldstraw
The Journal of Thoracic and Cardiovascular Surgery 2010, Volume 140, Number 1; 32-38

Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery
C. Moser,
 I. Opitz, W. Zhai, V. Rousson, E. W. Russi, W. Weder, D. Lardinois
The Journal of Thoracic and Cardiovascular Surgery 2008, Volume 136, Number 4; 843-849

The effect of autologous fibrin sealant (Vivostat) on morbidity after pulmonary Lobectomi - a prospective randomized, blinded study
A. Belboul, L. Dernevik, O. Aljassim, B. Skrbic, G. Rådberg, D. Roberts 
European Journal of Cardio-thoracic Surgery 2004; 26: 1187–1191

A prospective randomized trial comparing homologous and autologous fibrin sealants for the control of alveolar air leak
B. Kılıç, E.Erşen, A. Demirkaya, H. Volkan Kara, N. Alizade, M. İşcan, K. Kaynak, A. Turna
European Journal of Thoracic Disease 2017; 9(9): 2915-2922

Autologous Fibrin sealant (Vivostat) in General Surgery Post interventional survey at three exemplary patients
J. Jacobs
Department of Thoracic Surgery and Thoracic Endoscopy; Essen, Germany

Autologer Fibrinkleber in der Thoraxchirurgie Machbarkeitsstudie in einen Zentrum 
J. Jacobs, S. Welter, M. Altmayer, A. Breull, G. Stamatis 
Presented at DACH 2010